BioCentury
ARTICLE | Clinical News

Lilly Icos present Phase II data for Cialis

November 28, 2000 8:00 AM UTC

Lilly Icos (Indianapolis, Ind.), a joint venture between Icos (ICOS) and Eli Lilly (LLY), presented data from a 212-patient Phase II trial of Cialis ( IC351), a phosphodiesterase type 5 ( PDE5) inhibi...